BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34719964)

  • 21. Clinicopathologic features predicting involvement of non- sentinel axillary lymph nodes in Iranian women with breast cancer.
    Moosavi SA; Abdirad A; Omranipour R; Hadji M; Razavi AE; Najafi M
    Asian Pac J Cancer Prev; 2014; 15(17):7049-54. PubMed ID: 25227789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node.
    Mittendorf EA; Hunt KK; Boughey JC; Bassett R; Degnim AC; Harrell R; Yi M; Meric-Bernstam F; Ross MI; Babiera GV; Kuerer HM; Hwang RF
    Ann Surg; 2012 Jan; 255(1):109-15. PubMed ID: 22167004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness analyses demonstrate that observation is superior to sentinel lymph node biopsy for postmenopausal women with HR + breast cancer and negative axillary ultrasound.
    McEvoy AM; Poplack S; Nickel K; Olsen MA; Ademuyiwa F; Zoberi I; Odom E; Yu J; Chang SH; Gillanders WE
    Breast Cancer Res Treat; 2020 Sep; 183(2):251-262. PubMed ID: 32651755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. De-escalation of axillary treatment in the event of a positive sentinel lymph node biopsy in cT1-2 N0 breast cancer treated with mastectomy: nationwide registry study (BOOG 2013-07).
    de Wild SR; van Roozendaal LM; de Wilt JHW; van Dalen T; van der Hage JA; van Duijnhoven FH; Simons JM; Schipper RJ; de Munck L; van Kuijk SMJ; Boersma LJ; Linn SC; Lobbes MBI; Poortmans PMP; Tjan-Heijnen VCG; van de Vijver KKBT; de Vries J; Westenberg AH; Strobbe LJA; Smidt ML
    Br J Surg; 2024 Apr; 111(4):. PubMed ID: 38597154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and validation of a pre- and intra-operative scoring system that distinguishes between non-advanced and advanced axillary lymph node metastasis in breast cancer with positive sentinel lymph nodes: a retrospective study.
    Murata T; Watase C; Shiino S; Kurita A; Ogawa A; Jimbo K; Iwamoto E; Yoshida M; Takayama S; Suto A
    World J Surg Oncol; 2022 Sep; 20(1):314. PubMed ID: 36171615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nomogram to predict non-sentinel lymph node status using total tumor load determined by one-step nucleic acid amplification: first report from Thailand.
    Sa-Nguanraksa D; O-Charoenrat E; Kulprom A; Samarnthai N; Lohsiriwat V; Nimpoonsri K; O-Charoenrat P
    Breast Cancer; 2019 Jul; 26(4):471-477. PubMed ID: 30617675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors and prognosis of sentinel lymph node metastasis in breast-conserving breast cancer: A retrospective study based on the SEER database.
    Liu R; Chen J; Cao W; Li T; Liao Y; Li Y
    Medicine (Baltimore); 2024 Mar; 103(9):e37263. PubMed ID: 38428869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anatomical site and size of sentinel lymph node metastasis predicted additional axillary tumour burden and breast cancer survival.
    Lai BS; Tsang JY; Li JJ; Poon IK; Tse GM
    Histopathology; 2023 May; 82(6):899-911. PubMed ID: 36723261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and external validation of a nomogram to predict four or more positive nodes in breast cancer patients with one to three positive sentinel lymph nodes.
    Yang Z; Lan X; Huang Z; Yang Y; Tang Y; Jing H; Wang J; Zhang J; Wang X; Gao J; Wang J; Xuan L; Fang Y; Ying J; Li Y; Huang X; Wang S
    Breast; 2020 Oct; 53():143-151. PubMed ID: 32823167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative axillary ultrasound in breast cancer: safely avoiding frozen section of sentinel lymph nodes in breast-conserving surgery.
    Ibrahim-Zada I; Grant CS; Glazebrook KN; Boughey JC
    J Am Coll Surg; 2013 Jul; 217(1):7-15; discussion 15-6. PubMed ID: 23628226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imaging features of sentinel lymph node mapped by multidetector-row computed tomography lymphography in predicting axillary lymph node metastasis.
    Ou X; Zhu J; Qu Y; Wang C; Wang B; Xu X; Wang Y; Wen H; Ma A; Liu X; Zou X; Wen Z
    BMC Med Imaging; 2021 Dec; 21(1):193. PubMed ID: 34911489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of non-sentinel lymph node metastasis in breast cancer patients.
    Goyal A; Douglas-Jones A; Newcombe RG; Mansel RE;
    Eur J Cancer; 2004 Jul; 40(11):1731-7. PubMed ID: 15251163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative analysis of axillary nodal burden in ultrasound/biopsy positive axilla vs ultrasound negative sentinel lymph node biopsy positive axilla.
    Tandon M; Ball W; Kirby R; Soumian S; Narayanan S
    Breast Dis; 2019; 38(3-4):93-96. PubMed ID: 30909179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer.
    Choi SH; Barsky SH; Chang HR
    Breast J; 2003; 9(3):153-62. PubMed ID: 12752622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sentinel lymphadenectomy without systematic axillary dissection in breast cancer patients: predictors of non-sentinel lymph node metastasis.
    Travagli JP; Atallah D; Mathieu MC; Rochard F; Camatte S; Lumbroso J; Garbay JR; Rouzier R
    Eur J Surg Oncol; 2003 May; 29(4):403-6. PubMed ID: 12711299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes.
    Pohlodek K; Bozikova S; Meciarova I; Mucha V; Bartova M; Ondrias F
    Neoplasma; 2016; 63(3):427-34. PubMed ID: 26925789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel nomogram for the preoperative prediction of sentinel lymph node metastasis in breast cancer.
    Wang XF; Zhang GC; Zuo ZC; Zhu QL; Liu ZZ; Wu SF; Li JX; Du JH; Yan CL; Ma XY; Shi Y; Shi H; Zhou YD; Mao F; Lin Y; Shen SJ; Zhang XH; Sun Q
    Cancer Med; 2023 Mar; 12(6):7039-7050. PubMed ID: 36524283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Dutch Prediction Tool to Assess the Risk of Additional Axillary Non-Sentinel Lymph Node Involvement in Sentinel Node-Positive Breast Cancer Patients.
    van den Hoven I; van Klaveren D; Voogd AC; Vergouwe Y; Tjan-Heijnen V; Roumen RM
    Clin Breast Cancer; 2016 Apr; 16(2):123-30. PubMed ID: 26602438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How much does axillary ultrasound contribute in women undergoing breast-conserving surgery with no palpable axillary nodes?
    Preda T; McGrath R; Bingham J; Fawcett A; O'Dea C; Bochner M; Gill PG; Kollias J
    ANZ J Surg; 2020 Jun; 90(6):1146-1150. PubMed ID: 31957192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Would Removal of All Ultrasound Abnormal Metastatic Lymph Nodes Without Sentinel Lymph Node Biopsy Be Accurate in Patients with Breast Cancer with Neoadjuvant Chemotherapy?
    Lim GH; Gudi M; Teo SY; Ng RP; Yan Z; Lee YS; Allen JC; Leong LCH
    Oncologist; 2020 Nov; 25(11):e1621-e1627. PubMed ID: 32537791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.